ESTRO 2024 - Abstract Book

S2146

Clinical - Upper GI

ESTRO 2024

16.Huang R, Guo H, Chen J, et al. Intratreatment tumor volume change during definitive chemoradiotherapy is predictive for treatment outcome of patients with esophageal carcinoma. Cancer Manag Res. 2020;12:7331-7339.

17.Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol. 2017;12(1):36-42.

18.Sok M, Zavrl M, Greif B, Srpčič M. Objective assessment of WHO/ECOG performance status. Support Care Cancer. 2019;27:3793-3798.

19.Zhang L, Fried DV, Fave XJ, Hunter LA, Yang J, Court LE. IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. Med Phys. 2015;42(3):1341-1353.

20.Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213.

21.Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247.

22.Chen F-P, Wen D-W, Li F, et al. The role of post-neoadjuvant chemotherapy tumor volume for prognostication and treatment guidance in loco-regionally advanced nasopharyngeal carcinoma. Cancers. 2019;11(11):1632.

23.Adrian G, Carlsson H, Kjellén E, et al. Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy. Radiat Oncol. 2022;17(1):1-13.

24.Kuo C-FJ, Ke B-H, Wu N-Y, Kuo J, Hsu H-H. Prognostic value of tumor volume for patients with advanced lung cancer treated with chemotherapy. Comput Methods Programs Biomed. 2017;144:165-177.

25.Li D, Zhang Q, Yang Y, Yin H, Zhu C, Li X. Significance of intratreatment tumor volume change during chemoradiotherapy for potentially resectable thoracic esophageal squamous cell carcinoma. Am J Transl Res. 2022;14(7):4776.

26.Azab B, Amundson JR, Picado O, et al. Impact of chemoradiation-to-surgery interval on pathological complete response and short-and long-term overall survival in esophageal cancer patients. Ann Surg Oncol. 2019;26:861-868.

27.Lv J, Gan H, Zhang W, Pan L, Wang R, Qin Y. Relative tumor volume is a better independent prognostic factor in esophageal squamous cell carcinoma: results of a retrospective study. Medicine (Baltimore). 2019;98(14).

438

Mini-Oral

Less pneumonia after nCRT and resection in oesophageal cancer using proton RT

Mark L. Frederiks 1 , Boudewijn van Etten 2 , Wendy Kelder 3 , Margriet Dieters 1 , Jannet C. Beukema 1 , Charlotte IJsbrandy 1 , Jacco J. de Haan 4 , Erik W. Korevaar 1 , Jan Willem Haveman 2 , Ewoud Schuit 5 , Johannes A. Langendijk 1 , Christina T. Muijs 1